FDA recall, , Moderate risk
LifeShare Blood Center Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from an unsuitable donor due to a donor screening deviation.
Recall ended Jun 4, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeShare Blood Center began a recall of Red Blood Cells, Leukocytes Reduced on March 7, 2025, because the blood product was collected from an unsuitable donor due to a donor screening deviation. The FDA added the recall to its Enforcement Report and classified it on June 4, 2026, and it was listed in the FDA's weekly enforcement report on June 10, 2026. The recall affects blood products distributed in Arkansas.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeShare Blood Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98846
- Recall number
- B-0073-2026
All recalls from LifeShare Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
